BONA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 495
EU - Europa 260
AS - Asia 115
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 874
Nazione #
US - Stati Uniti d'America 494
IT - Italia 108
CN - Cina 67
SE - Svezia 51
IE - Irlanda 48
BE - Belgio 13
UA - Ucraina 9
DE - Germania 8
FI - Finlandia 8
JP - Giappone 8
KR - Corea 8
TR - Turchia 7
FR - Francia 6
UZ - Uzbekistan 5
IN - India 4
PH - Filippine 4
VN - Vietnam 4
GR - Grecia 3
OM - Oman 3
BR - Brasile 2
CH - Svizzera 2
HK - Hong Kong 2
IL - Israele 2
AU - Australia 1
CA - Canada 1
ES - Italia 1
GB - Regno Unito 1
ID - Indonesia 1
PL - Polonia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 874
Città #
Chandler 137
Dublin 48
Ashburn 38
Turin 27
Nyköping 26
Beijing 19
Fairfield 15
Medford 15
Brussels 13
Torino 13
Princeton 12
Hangzhou 11
Ann Arbor 9
Wilmington 9
Rome 7
Seoul 7
Cambridge 6
Houston 6
Redwood City 6
Woodbridge 6
Boston 5
Dearborn 5
Guangzhou 5
Hebei 5
Istanbul 5
Milan 5
Chengdu 4
Jacksonville 4
New York 4
Nichelino 4
San Mateo 4
Seattle 4
Albignasego 3
Alessandria 3
Changsha 3
Dong Ket 3
Helsinki 3
Lappeenranta 3
Muscat 3
Stockholm 3
Villeurbanne 3
Athens 2
Boardman 2
Buffalo 2
Böblingen 2
Charleston 2
Chongqing 2
Fremont 2
Gioia del Colle 2
Guiyang 2
Konya 2
La Tour-de-Peilz 2
Las Vegas 2
Messina 2
Nishikicho 2
Novara 2
Petriolo 2
Piemonte 2
Pune 2
Shiyan 2
Tel Aviv 2
Waghäusel 2
Absecon 1
Americana 1
Bologna 1
Bronx 1
Central District 1
Châtillon 1
Cochin 1
Dandong 1
Falls Church 1
Fukuoka 1
Geldern 1
Ichibacho 1
Indiana 1
Jakarta 1
Jinan 1
Katy 1
Lama Mocogno 1
Madrid 1
Muizenberg 1
Mumbai 1
Nanchang 1
Niles 1
Norwalk 1
Olbersdorf 1
Padova 1
Peschiera 1
Piraeus 1
Poznan 1
San Diego 1
Shenzhen 1
Southend 1
Sydney 1
Toronto 1
Upper Marlboro 1
Valle 1
Washington 1
Wuhan 1
Yokohama 1
Totale 591
Nome #
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 172
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 75
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 73
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 64
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 59
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 54
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 51
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication? 44
Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood 43
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 43
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 39
The prevalence of silent acromegaly in prolactinomas is very low 33
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 25
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 23
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 22
Neuroendocrine response to diclofenac in healthy subjects: a pilot study. 20
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 17
Psychiatric disorders and anger in patients with controlled acromegaly 17
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 17
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 13
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 11
Isolated anterior pituitary dysfunction in adulthood 11
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 10
Totale 936
Categoria #
all - tutte 4.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 1 7 8 3 7 4 4 3 2
2020/2021123 2 9 5 6 21 7 24 16 10 1 5 17
2021/2022184 5 8 11 7 10 15 10 8 11 22 41 36
2022/2023386 27 36 5 39 34 75 18 17 49 29 34 23
2023/2024186 26 37 14 15 13 21 19 41 0 0 0 0
Totale 936